Dr. Jacob Cogan, MD
Hematology (Hematology (Internal Medicine) Physician)
- Medicare participating
At a glance
- Years since graduation
- 10
- In the NPI registry since
- 2016
- Medicare patients seen, 2024
- 96
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2016Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology (Internal Medicine) Physician primary
MN license 70880
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- M Health Fairview University of Mn Medical Center Minneapolis, MN
- M Health Fairview St John's Hospital Maplewood, MN
Medical groups
- Fairview Express Care (1,911 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 96
- Services billed
- 203
- Patients’ average age
- 63
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 26 | 15 |
| New patient office or other outpatient visit, 45-59 minutes | 12 | 12 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 12 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Minneapolis, MN | 78 |
| Xarelto (rivaroxaban) Other prescribers in Minneapolis, MN | 33 |
| Lactated Ringers (ringer's solution,lactated) | 19 |
| Fluconazole-Nacl (fluconazole in nacl,iso-osm) | 18 |
| Hydroxyurea Other prescribers in Minneapolis, MN | 13 |
| Pantoprazole Sodium Other prescribers in Minneapolis, MN | 12 |
| Famotidine Other prescribers in Minneapolis, MN | 11 |
| Sunitinib Malate | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $32,623 in research payments for these studies, mostly to the institutions running them.
- A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia
Genzyme Corporation · Active, not recruiting · NCT05662319
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.